MCP compliance catalog

Every MCP tool in the SCOPE compliance index, grouped by server — risk posture, regulatory exposure, and the tools that warrant tighter governance.
303MCP servers
4476tools
Reset 303 of 303 servers
Intapp Celeste
10 tools · footprint 18
2 high 4 med 4 low
Intercom
13 tools · footprint 18
8 med 5 low
LunarCrush
15 tools · footprint 18
8 med 7 low
Mixpanel
23 tools · footprint 18
1 high 6 med 16 low
Slack
7 tools · footprint 18
2 high 4 med 1 low
Adobe Customer Journey Analytics
25 tools · footprint 17
1 high 5 med 19 low
Campfire
12 tools · footprint 17
7 med 5 low
Canva
32 tools · footprint 17
7 med 25 low
Circleback
11 tools · footprint 17
2 high 3 med 6 low
Dremio Cloud
11 tools · footprint 17
1 critical 1 high 1 med 8 low
Firecrawl
19 tools · footprint 17
7 med 12 low
Granola
6 tools · footprint 17
3 high 1 med 2 low
iManage Work
14 tools · footprint 17
1 high 5 med 8 low
Jotform
5 tools · footprint 17
1 high 2 med 2 low
Mermaid Chart
25 tools · footprint 17
1 high 2 med 22 low
Todoist
25 tools · footprint 17
7 med 18 low
‹ PrevPage 8 of 19Next ›
AdisInsight
4 low · 4 tools · 0 SoD-flagged
regimes none

Tools needing tighter control (0 of 4)

None — every tool is low-risk, high-confidence, and outside PCI/HIPAA payload scope.
All other tools (4)
adisinsight.get_drug low conf mediumallow
Returns a full drug profile including development history, aggregate adverse-event data, organizations, and brand names from the Adis intelligence database.
adisinsight.get_trial low conf mediumallow
Returns a complete clinical-trial profile including investigators, study centres, compounds, indications, endpoints, and eligibility criteria from published trial intelligence.
adisinsight.search_drugs low conf mediumallow
Queries the Adis pharmaceutical database across drug name, therapeutic area, developer, mechanism, phase, and 60+ filters, returning commercial drug-intelligence results only.
adisinsight.search_trials low conf mediumallow
Searches clinical-trial records by condition, sponsor, compound, phase, status, and demographic criteria, exposing competitive trial-intelligence but no individual patient records.